Advertisement
  • A New Look for Clinical Trials

    More focused efforts aim to increase the number and type of participants in research studies. One goal is for study participants to be more like the patients who will take the drug if it is approved.

    by Sue Rochman

  • The Kindest Cut

    Before undergoing surgery, cancer patients should look for experienced surgeons, get second opinions and ask about the risks and benefits.

    by Stephen Ornes

  • Going Off-Label

    Physicians are legally permitted to prescribe drugs approved for one purpose to be used for another, a practice called off-label prescribing. The rise of targeted therapies and immunotherapies is creating new challenges for navigating off-label options.

    by Kate Yandell

  • A Focus on Pediatric Cancer Screening

    The AACR shares research papers that summarize recommendations for monitoring children and adolescents with cancer predisposition syndromes.

    by Garrett M. Brodeur

  • Revised Prostate Cancer Screening Guidelines Proposed

    The U.S. Preventive Services Task Force suggests an individualized approach to prostate cancer screening.

  • Immunotherapy Combinations

    Researchers are combining immunotherapies with each other and with other treatments in hopes that a larger proportion of patients will have long-term benefits.

    by Kate Yandell

  • A Prescription for Prevention?

    Scientists are working to understand the molecular processes that transform normal cells into cancer cells in the hope they can prevent the disease before it starts.

    by Marci A. Landsmann

  • Seeking a Second Opinion

    Another perspective on your disease may help you find the best cancer care.

    by Stephen Ornes

  • Healthy Habits

    Tanning Trouble

    Indoor tanning is a major culprit in melanoma diagnosed early in life.

    by Kate Yandell

  • Forward Look

    Inside Inflammation

    Q&A with molecular biologist Michael Karin on inflammation and cancer.

    by Robin Meadows